SPL 9.20% 9.5¢ starpharma holdings limited

yes but not blame HQ staff but only management team of 4 people...

  1. 321 Posts.
    lightbulb Created with Sketch. 84
    yes but not blame HQ staff but only management team of 4 people at SPL HQ who weak at delivering value - Jacky and Eglezes and Paull- not real clinical trials data and no good commercial deals for years. The only things accelerated are own pay packets.

    DEP gemcitibine should go into clinic trial years ago. How it takes from 2018/19 when show preclinical studies to now 2022 and no progress to see. Is there problem in manufacture, toxicology or no interest from doctors ? jacky should tell SH what going on. Lol- JK- that crazy!!
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.008(9.20%)
Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.